2013 Annual Meeting Archive Education Symposia

2013 Annual Meeting Archive Education Symposia

2013 Annual Meeting Archive > 2013 Annual Meeting Education Symposia

2013 Annual Meeting Education Symposia

Education Symposium I: Unraveling the Mystery of TCGA
Education Symposium II: Survivorship and Symptom Management
Education Symposium III: The Future of Screening: Biomarker and Radiologic Advances
2013 Annual Meeting Montz Symposia

2013 Annual Meeting Education Symposium I

Education Symposium I: Unraveling the Mystery of TCGA, Abstracts 7-11

Moderators:
Christopher Crum, Brigham and Women’s Hospital
Douglas Levine, MD, Memorial Sloan-Kettering Cancer Center

Abstract 7

A novel strategy to identify ovarian cancer molecular signaling pathways and drug repurposing candidates

E. Al Sawah, D. Marchion, Y. Xiong, I. Ramirez-Diaz, F. Abbasi, N. Bou Zgheib, X. Stickles, P. Judson Lancaster, R. Wenham, J. Lancaster

H. Lee Moffitt Cancer Center, Tampa, FL

Abstract 8

Identification of master regulators of cisplatin resistance in ovarian cancer

H. Dinkelspiel, A. Iyer, C. Lefebvre, J. Wright, S. Lewin, T. Herzog, J. Kitajewski, A. Califano

Columbia University College of Physicians and Surgeons, New York, NY

Abstract 9

Molecular determinants for lymph node metastasis in early-stage endometrial cancer

N. Bou Zgheib1, D. Marchion2, I. RAMIREZ2, P. Teefey1, P. Judson Lancaster2, R. Wenham2, S. Apte2, J. Lancaster2, J. Gonzalez Bosquet2

1University of South Florida College of Medicine, Tampa, FL, 2H. Lee Moffitt Cancer Center, Tampa, FL

Abstract 10

Separating the good, the bad, and the ugly: New directions in genomic prediction of outcome in ovarian cancer

B. Zand1, C. Ivan2, C. Pecot2, R. Rupaimoole2, H. Dalton2, J. Bottsford-Miller2, W. Hu2, A. Nick2, A. Sood2

1University of Texas M.D. Anderson Cancer Center, Houston, TX, 2The University of Texas, MD Anderson Cancer Center, Houston, TX

Abstract 11

The Eph family: Not playing nice in uterine cancer

H. Dalton, C. Ivan, C. Pecot, R. Rupaimoole, B. Zand, J. Bottsford-Miller, W. Hu, A. Nick, R. Coleman, A. Sood

The University of Texas, MD Anderson Cancer Center, Houston, TX

2013 Annual Meeting Education Symposium II

Education Symposium II: Survivorship and Symptom Management, Abstracts 12-17

Moderators:
Paula Anastasia, MN, RN, AOCN, Cedars Sinai Medical Center
Cecelia Boardman, MD, Medical College of Virginia

Abstract 12

Cognitive function during chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: A Gynecologic Oncology Group study

L. Hess1, H. Huang2, W. Robinson3, R. Johnson4, D. Alberts5

1Indiana University School of Medicine, Indianapolis, IN, 2Gynecologic Oncology Group, Buffalo, NY, 3Tulane Medical School, New Orleans, LA, 4Kansas University Medical Center, Westwood, KS, 5The University of Arizona Cancer Center, Tucson, AZ

Abstract 13

Sleep Disturbances: A critical issue among gynecologic cancer survivors

C. Tung1, S. Westin2, C. Sun2, R. Lacour3, L. Meyer4, M. Schlumbrecht5, D. Bodurka2

1Baylor College of Medicine, Houston, TX, 2The University of Texas, MD Anderson Cancer Center, Houston, TX, 3Louisiana State University Health Science Center, Shreveport, LA, 4University of Texas Medical School at Houston, Houston, TX, 5Banner Health M.D. Anderson Cancer Center, Houston, TX

Abstract 14

Spirituality, depression and interleukin-6 in ovarian cancer patients

P. Thaker1, S. Cole2, S. Lutgendorf3, D. Bender3, A. Ahmed3, M. Goodheart3, J. Lucci4, A. Sood5

1Washington University School of Medicine, St. Louis, MO, 2UCLA Cedars Sinai Medical Center, Los Angeles, CA, 3University of Iowa Hospitals and Clinics, Iowa City, IA, 4University of Miami Sylvester Cancer Center, Miami, FL, 5The University of Texas, MD Anderson Cancer Center, Houston, TX

Abstract 15

The ADVOCATE Study (Advanced Ovarian Cancer: Care & Treatment Experiences)

V. Jenkins1, S. Catt2, C. Langridge2, L. Fallowfield2

1University of Sussex, Brighton, East Sussex, 2University of Sussex, East Sussex, United Kingdom

Abstract 16

Results of timely palliative medicine consultation on end-of-life Care outcomes for women with gynecologic malignancies

N. Nevadunsky, S. Gordon, L. Spoozak, K. Harris, E. Rivera, A. Van Arsdale, B. Rapkin, P. Selwyn, G. Goldberg

Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

Abstract 17

Palliative medicine consultation at the end-of-life decreases inpatient hospital costs in women with gynecologic malignancies

N. Nevadunsky, S. Gordon, L. Spoozak, K. Harris, E. Rivera, A. Van Arsdale, B. Rapkin, P. Selwyn, G. Goldberg

Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

2013 Annual Meeting Education Symposium III

Education Symposium III: The Future of Screening: Biomarker and Radiologic Advances, Abstracts 49-52

Moderators:
Elise Kohn, MD, National Cancer Institute
Anil Sood, MD, The University of Texas, MD Anderson Cancer Center

Abstract 49

Serial use of tumor morphology index during ultrasound-based screening may reduce false-positive results

F. Ueland1, E. Elliott2, R. Miller2, J. Ubellacker2, C. DeSimone2, J. Elder2, J. Hoff2, R. Kryscio2, J. van Nagell, Jr2, E. Pavlik2

1University of Kentucky Medical Center, Lexington, KY, 2Unversity of Kentucky, Lexington, KY

Abstract 50

An evaluation of molecular markers that predict maximal surgical cytoreduction: A Gynecologic Oncology Group trial

C. Miller1, A. Miller2, C. Hamilton3, A. Alvarez-Secord4, L. Havrilesky4, F. Muggia5, J. Farley6

1Brooke Army Medical Center, Ft. Sam Houston, TX, 2GOG Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY, 3Walter Reed National Military Medical Center: Gynecologic Cancer Center of Excellence, Bethesda, MD, 4Duke University Medical Center, Durham, NC, 5New York University Medical Center, New York, NY, 6St. Joseph’s Hospital and Medical Center, Phoenix, AZ

Abstract 51

Impact of preoperative and pretreatment CA125 on survival of women with optimal cytoreduced ovarian and primary peritoneal cancer: A Gynecologic Oncology Group ancillary data study

N. Horowitz1, A. Miller2, B. Rungruang3, S. Richard4, N. Rodriguez5, M. Bookman6, C. Hamilton7, G. Maxwell8, T. Krivak9

1Brigham & Women’s Hospital/Dana Farber Cancer Institute, Boston, MA, 2Gynecologic Oncology Group, Buffalo, NY, 3University of Pittsburg/Magee Women’s Hospital, Pittsburg, PA, 4Hahnemann University Hospital, Philadelphia, PA, 5Loma Linda University Medical Center, Loma Linda, CA, 6University of Arizona, Tuscon, AZ, 7Walter Reed Army Medical Center, Washington, DC, 8Inova Fairfax Hospital, Fairfax, VA, 9Magee-Womens Hospital of UPMC, Pittsburgh, PA

Abstract 52

Glycomics analysis as a potential diagnostic test for ovarian cancer

G. Leiserowitz1, K. Kim1, S. Miyamoto1, R. Ruhaak2, S. Hua2, L. Dimpasoc2, C. Williams2, C. Lebrilla2

1UC Davis School of Medicine, Sacramento, CA, 2University of California Davis, Sacramento, CA

2013 Annual Meeting Montz Symposia

Montz Symposium A & B: Surgical Mishaps

Moderator:
Mario Leitao, MD, Memorial Sloan-Kettering Cancer Center,
New York, NY

We have all seen videos of perfect and bloodless surgical procedures. However, as surgeons, we also know that not every case goes as desired and we sometimes find ourselves having to manage difficult situations either during or after surgery. Mishaps and complications occur and its part of being a surgeon. What is unacceptable is not learn and evolve from these mishaps. Course faculty will demonstrate challenging situations encountered during surgical procedures and provide expert advice on how to prevent and manage these situations. Guest faculty Glenn Dopf, JD, LLM, an experienced trial attorney who defends doctors and hospitals, will provide expert advice when these unexpected mishaps delve into the legal world.

Course Faculty:
Robert Debernardo, MD, Case Western Reserve – Mac Donald Women’s Hospital, Cleveland, OH
Ram Eitan, MD, Rabin Medical Center, Tel Aviv University, Sackler School of Medicine,
Petah Tikva, Israel
Pedro Escobar, MD, The Cleveland Clinic Foundation, Cleveland, OH
Michael Frumovitz, MD, MPH, The University of Texas, MD Anderson Cancer Center, Houston, TX
Glenn Dopf, JD, LL.M, Dopf P.C, New York, NY